ZnO NPs enhanced cellular uptake and the tumor spheroid penetration of DOX by inhibiting P-glycoprotein (Pgp)-mediated drug efflux and three-dimensional (3D) spheroid architecture-induced drug resistance, leading to the efficient killing of cancer and cancer stem cells. Here, PGP is linked to cancer.